Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Exogenous IL-33 Restores Dendritic Cell Activation and Maturation in Established Cancer
Authors
Keywords
-
Journal
JOURNAL OF IMMUNOLOGY
Volume 198, Issue 3, Pages 1365-1375
Publisher
The American Association of Immunologists
Online
2016-12-24
DOI
10.4049/jimmunol.1501399
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IL-33 facilitates oncogene-induced cholangiocarcinoma in mice by an interleukin-6-sensitive mechanism
- (2015) Daisaku Yamada et al. HEPATOLOGY
- T-bet– and STAT4–dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses
- (2015) Claudia Baumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-33/ST2 pathway contributes to metastasis of human colorectal cancer
- (2014) Xuejian Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dynamics of the IL-33/ST2 network in the progression of human colorectal adenoma to sporadic colorectal cancer
- (2014) Guanglin Cui et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Alarmin IL-33 Acts as an Immunoadjuvant to Enhance Antigen-Specific Tumor Immunity
- (2014) Daniel O. Villarreal et al. CANCER RESEARCH
- Host miR155 Promotes Tumor Growth through a Myeloid-Derived Suppressor Cell-Dependent Mechanism
- (2014) S. Chen et al. CANCER RESEARCH
- Interleukin 33: a switch-hitting cytokine
- (2014) Daniel O Villarreal et al. CURRENT OPINION IN IMMUNOLOGY
- Skin exposure promotes a Th2-dependent sensitization to peanut allergens
- (2014) Leticia Tordesillas et al. JOURNAL OF CLINICAL INVESTIGATION
- Biliary repair and carcinogenesis are mediated by IL-33–dependent cholangiocyte proliferation
- (2014) Jun Li et al. JOURNAL OF CLINICAL INVESTIGATION
- IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes
- (2014) N. E. Humphreys et al. JOURNAL OF IMMUNOLOGY
- IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4
- (2014) M. Kurowska-Stolarska et al. JOURNAL OF IMMUNOLOGY
- Tumoral Expression of IL-33 Inhibits Tumor Growth and Modifies the Tumor Microenvironment through CD8+T and NK Cells
- (2014) Xin Gao et al. JOURNAL OF IMMUNOLOGY
- Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity
- (2014) J Y Kim et al. ONCOGENE
- High Serum Levels of the Interleukin-33 Receptor Soluble ST2 as a Negative Prognostic Factor in Hepatocellular Carcinoma
- (2014) Dominik Bergis et al. Translational Oncology
- BRAF Inhibition Alleviates Immune Suppression in Murine Autochthonous Melanoma
- (2014) S. M. Steinberg et al. Cancer Immunology Research
- Transgenic expression of IL-33 activates CD8+ T cells and NK cells and inhibits tumor growth and metastasis in mice
- (2013) Kun Gao et al. CANCER LETTERS
- The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy
- (2013) Amy E Moran et al. CURRENT OPINION IN IMMUNOLOGY
- Interleukin-33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
- (2013) Ivan P. Jovanovic et al. INTERNATIONAL JOURNAL OF CANCER
- Special aspects of interleukin-33 and the IL-33 receptor complex
- (2013) Michael U. Martin SEMINARS IN IMMUNOLOGY
- Targeting BRAFV600E in an Inducible Murine Model of Melanoma
- (2012) Anna I. Hooijkaas et al. AMERICAN JOURNAL OF PATHOLOGY
- IL-33/ST2 axis in inflammation and immunopathology
- (2012) Marija Milovanovic et al. IMMUNOLOGIC RESEARCH
- The Use of Agonistic Anti-CD40 Therapy in Treatments for Cancer
- (2012) Andrea Khong et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- IL-33 and ST2 in Atopic Dermatitis: Expression Profiles and Modulation by Triggering Factors
- (2012) Terhi Savinko et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
- (2012) W. V. Bonilla et al. SCIENCE
- Serum Interleukin-33 Levels in Patients with Gastric Cancer
- (2011) Pinghu Sun et al. DIGESTIVE DISEASES AND SCIENCES
- IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+T cells
- (2011) Qianting Yang et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-33-activated dendritic cells are critical for allergic airway inflammation
- (2011) Anne-Gaëlle Besnard et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- ST2 deletion enhances innate and acquired immunity to murine mammary carcinoma
- (2011) Ivan Jovanovic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-33 Expands Suppressive CD11b+ Gr-1int and Regulatory T Cells, including ST2L+ Foxp3+ Cells, and Mediates Regulatory T Cell-Dependent Promotion of Cardiac Allograft Survival
- (2011) H. R. Turnquist et al. JOURNAL OF IMMUNOLOGY
- Interleukin-33 biology with potential insights into human diseases
- (2011) Gaby Palmer et al. Nature Reviews Rheumatology
- Gene expression profiling identifies sST2 as an effector of ErbB2-driven breast carcinoma cell motility, associated with metastasis
- (2011) J Gillibert-Duplantier et al. ONCOGENE
- Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
- (2010) Ilia N. Buhtoiarov et al. IMMUNOLOGY
- IL-33 promotes DC development in BM culture by triggering GM-CSF production
- (2009) Nobuyasu Mayuzumi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- IL-33 receptor (T1/ST2) signalling is necessary to prevent the development of encephalitis in mice infected withToxoplasma gondii
- (2009) Leigh A. Jones et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Dendritic cells integrate signals from the tumor microenvironment to modulate immunity and tumor growth
- (2009) Albert Lin et al. IMMUNOLOGY LETTERS
- IL-33–activated dendritic cells induce an atypical TH2-type response
- (2009) Matthew A. Rank et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dendritic Cells Require STAT-1 Phosphorylated at Its Transactivating Domain for the Induction of Peptide-Specific CTL
- (2009) A. Pilz et al. JOURNAL OF IMMUNOLOGY
- BrafV600E cooperates with Pten loss to induce metastatic melanoma
- (2009) David Dankort et al. NATURE GENETICS
- IL-33 reduces the development of atherosclerosis
- (2008) Ashley M. Miller et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?
- (2008) Christine Moussion et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now